• Nasodren Germany
• Nasodren Poland
• Nasodren Romania
• Sinuforte Russia
• Sinuforte Ukraine

• Home
• authorized licensees
• license out
• contact
• our partners

Documents

NASODREN ® | SINUFORTE ® NON-CONFIDENTIAL PRESENTATION

Last update on 6th of July 2009

Good quality

PDF (3.6Mb) Powerpoint presentation (3.3 Mb)

 

Low quality - Faster download

PDF low quality (1.9Mb) Powerpoint low-quality (2 Mb)

Those documents are password protected. To download them please get a password.

Index of contents:

• Sinusitis
• Definition of Sinusitis
• Prevalence of Sinusitis in recent years
• Sinusitis, and unmed need
• Nasodren / Sinuforte
• Product description
• Countries where is already marketed
• Mechanism of action
• Clinical trials and experience
• Endoscopic imaging studies
• Regulatory status
• Patents status
• Hartington Pharmaceutical
• History
• Mission
• Contact Information
• For discussions on potential licensing in the Americas, please contact:
• Mr. Colin B. Chan
• (o) +01 925-945-6944
• (m) +01 925-270-7177
• (em) colin@hartington.org
• For discussions on potential licensing in Europe, please contact:
• Mr. Thomas Riesterer
• (o) +49 761 4538829
• (m)+49 172 7631685
• (em) thomas.riesterer@hartington.org

More information

• what′s new?
• newsletter
• Congresses
• Gallery
• Videos
• for patients
• about rhinosinusitis

Experts

• Expert information
• expert opinion
• Documents
• Get a password

Find us on

• Facebook
• Youtube